4 results
To assess the long-term safety and tolerability of 35 mg and 70 mg RVT-101 in subjects with DLB
Primary• To assess the effects of RVT-101 versus placebo on global function as measured by the Clinician*s Interview-Based Impression of Change Plus Caregiver Input (CIBIC+) after 24 weeks of treatment• To assess the effects of RVT-101 versus…
Primary: To assess the proportion of patients with intervention failure at 12 months after dose reduction, defined as patients who have restarted their initial dose due to (expected) loss of major molecular response.
The objective of this clinical study is to assess the safety and effectiveness of the Bolt IVL System for the lithotripsy-enhanced percutaneous coronary intervention of de novo, calcified, stenotic coronary lesions prior to stenting. The data is…